HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENLIUS

64.800

+0.1000.15%

Volume:558.92K

Turnover:35.48M

Market Cap:35.22B

PE:38.90

High:64.900

Open:64.900

Low:62.050

Close:64.700

52wk High:92.000

52wk Low:15.200

Shares:543.49M

HK Float Shares:163.43M

Volume Ratio:0.90

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.666

ROE:27.54%

ROA:4.97%

PB:9.36

PE(LYR):38.90

PS:5.50

Loading ...

Overview Company News Filings

Hong Kong Stock Market Analysis | Various Manipulations Behind Many Strategies and Severe Volume Reduction Favours Consumer Giants

HK Movers | Biomedical Stocks Surge With TransThera Sciences up 42%

Tiger Newspress

HENLIUS Pioneers New Era of Perioperative Immunotherapy Monotherapy for Gastric Cancer, H-Drug Takes Early Lead in Market Potential Exceeding $6 Billion USD

Phase 3 Clinical Trial of Hansizhuang Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early Nda Submission

THOMSON REUTERS

HENLIUS (02696): Phase 3 Clinical Trial of Hansizhuang® (Serplulimab Injection) Combined with Chemotherapy for Gastric Cancer Neoadjuvant/Adjuvant Treatment Achieves Primary Endpoint

Shanghai Henlius Biotech Inc announces phase 3 trial success for Hansizhuang in gastric cancer

Shanghai Henlius Biotech - Phase 3 Study of Hansizhuang for Gastric Cancer Met Primary Endpoint

THOMSON REUTERS

Hong Kong Stock Alert | HENLIUS (02696) Surges Over 10% as FOSUN PHARMA's Middle East Office Officially Opens in Jeddah, Saudi Arabia

BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07

HENLIUS (02696): NMPA Approves Phase 1b/2 Clinical Trial Application for HLX43 Injection Combined with HLX07 in Advanced/Metastatic Solid Tumors

Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China

Shanghai Henlius Biotech Inc - Nmpa Approves Phase 1B/2 Trial for Hlx43 and Hlx07

THOMSON REUTERS

HENLIUS (02696): FDA Approves Phase 1 Clinical Trial Application for HLX13 as First-Line Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients

Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma

Shanghai Henlius Biotech Inc - FDA Approves Ind for Hlx13 for Unresectable Hcc

THOMSON REUTERS

HENLIUS (02696) Completes First Patient Dosing in China for International Multi-Center Phase 1 Clinical Trial of Independently Developed Pembrolizumab Biosimilar HLX17 in Patients with Various Resected Solid Tumors

Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours

What Recent Partnership News Means for Shanghai Henlius Biotech’s Valuation in 2025

Simply Wall St.

Is Shanghai Henlius Biotech (SEHK:2696) Fairly Valued? A Fresh Look at Current Market Expectations

Simply Wall St.

European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02696/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":64.8,"timestamp":1765526889006,"preClose":64.7,"halted":0,"volume":558918,"delay":0,"floatShares":163428541,"shares":543494853,"eps":1.6659089695247733,"marketStatus":"Market Closed","change":0.1,"latestTime":"12-12 16:08:09","open":64.9,"high":64.9,"low":62.05,"amount":35478432,"amplitude":0.044049,"askPrice":64.8,"askSize":600,"bidPrice":64.5,"bidSize":800,"shortable":3,"etf":0,"ttmEps":1.6736778217413304,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":64.7,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.9048932604742457,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","floatShares":163428541,"roa":"4.97%","roe":"27.54%","lyrEps":1.665909,"volumeRatio":0.9048932604742457,"shares":543494853,"dividePrice":0,"high":64.9,"amplitude":0.044049,"preClose":64.7,"low":62.05,"week52Low":15.2,"pbRate":"9.36","psRate":"5.50","week52High":92,"institutionHeld":0,"latestPrice":64.8,"committee":0.142857,"eps":1.6659089695247733,"divideRate":0,"volume":558918,"delay":0,"ttmEps":1.6736778217413304,"open":64.9,"prevYearClose":23.7,"prevWeekClose":67.55,"prevMonthClose":69.05,"prevQuarterClose":75.3,"fiveDayClose":67.55,"twentyDayClose":67.1,"sixtyDayClose":82.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02696\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null},{"date":"2025-03-24","symbol":"02696","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2025-02-10","symbol":"02696","reason":null,"defaultRemindTime":1739151000000,"announcedDate":"2024-12-23","type":"delisting","dateTimestamp":1739116800000},{"market":"HK","date":"2024-08-26","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-21","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710984600000,"name":null,"time":"","dateTimestamp":1710950400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1761753600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02696","date":"2025-12-11","current":38.713277,"percent":0.857839,"low":-39.586964,"twenty":-13.477246,"median":-7.559702,"eighty":22.956206,"high":139.007258,"avg":9.914821,"sd":37.006433,"marketCap":35164116989},"quantilePoints":[{"date":"2020-12-18","current":-19.579463,"twenty":-33.232461,"median":-28.420437,"eighty":-20.87362,"marketCap":23370278679},{"date":"2020-12-24","current":-19.900439,"twenty":-32.90058,"median":-28.320519,"eighty":-20.447832,"marketCap":23777899818},{"date":"2020-12-31","current":-21.347266,"twenty":-32.738825,"median":-28.072361,"eighty":-20.405196,"marketCap":25517083348},{"date":"2021-01-08","current":-20.007648,"twenty":-21.027696,"median":-20.057143,"eighty":-19.872325,"marketCap":24131171473},{"date":"2021-01-15","current":-18.953047,"twenty":-20.538983,"median":-19.867005,"eighty":-19.394728,"marketCap":22826783826},{"date":"2021-01-22","current":-19.863933,"twenty":-20.368146,"median":-19.863933,"eighty":-19.394728,"marketCap":23913773532},{"date":"2021-01-29","current":-17.730953,"twenty":-20.273574,"median":-19.738569,"eighty":-18.960572,"marketCap":21522396178},{"date":"2021-02-05","current":-17.567528,"twenty":-20.124621,"median":-19.454728,"eighty":-18.3532,"marketCap":21196299267},{"date":"2021-02-11","current":-18.846812,"twenty":-20.037345,"median":-19.387263,"eighty":-18.043904,"marketCap":22772434340},{"date":"2021-02-19","current":-17.894416,"twenty":-19.98484,"median":-18.965589,"eighty":-17.952934,"marketCap":21631095149},{"date":"2021-02-26","current":-17.122755,"twenty":-19.887674,"median":-18.91395,"eighty":-17.817431,"marketCap":20652804414},{"date":"2021-03-05","current":-17.481999,"twenty":-19.859226,"median":-18.774495,"eighty":-17.800508,"marketCap":21033250811},{"date":"2021-03-12","current":-17.195892,"twenty":-19.837295,"median":-18.44057,"eighty":-17.499595,"marketCap":20652804414},{"date":"2021-03-19","current":-16.86211,"twenty":-19.790352,"median":-18.12726,"eighty":-17.253113,"marketCap":20245183274},{"date":"2021-03-26","current":-17.181113,"twenty":-19.623559,"median":-18.062887,"eighty":-17.138564,"marketCap":20272358016},{"date":"2021-04-01","current":-19.512345,"twenty":-19.512345,"median":-18.076073,"eighty":-17.177529,"marketCap":22962657539},{"date":"2021-04-09","current":-18.271256,"twenty":-19.510182,"median":-18.12726,"eighty":-17.179679,"marketCap":21549570921},{"date":"2021-04-16","current":-18.363013,"twenty":-19.476333,"median":-18.248673,"eighty":-17.18998,"marketCap":21739794120},{"date":"2021-04-23","current":-19.645162,"twenty":-19.476333,"median":-18.226089,"eighty":-17.316751,"marketCap":23315929193},{"date":"2021-04-30","current":-19.040057,"twenty":-19.648003,"median":-18.297927,"eighty":-17.448129,"marketCap":22690910112},{"date":"2021-05-07","current":-17.965945,"twenty":-19.565472,"median":-18.363013,"eighty":-17.482435,"marketCap":21549570921},{"date":"2021-05-14","current":-18.113671,"twenty":-19.510182,"median":-18.274791,"eighty":-17.482435,"marketCap":21712619377},{"date":"2021-05-21","current":-18.357986,"twenty":-19.487135,"median":-18.274791,"eighty":-17.516465,"marketCap":22011541546},{"date":"2021-05-28","current":-18.986811,"twenty":-19.432718,"median":-18.278327,"eighty":-17.567256,"marketCap":22989832281},{"date":"2021-06-04","current":-18.085054,"twenty":-19.394728,"median":-18.274791,"eighty":-17.569054,"marketCap":21794143605},{"date":"2021-06-11","current":-17.838307,"twenty":-19.380637,"median":-18.278327,"eighty":-17.596682,"marketCap":21495221436},{"date":"2021-06-18","current":-16.028857,"twenty":-19.316527,"median":-18.226089,"eighty":-17.499595,"marketCap":19158193568},{"date":"2021-06-25","current":-17.449469,"twenty":-19.090843,"median":-18.120466,"eighty":-17.407752,"marketCap":20843027612},{"date":"2021-07-02","current":-17.434433,"twenty":-19.054867,"median":-18.089655,"eighty":-17.397323,"marketCap":20788678127},{"date":"2021-07-09","current":-16.265645,"twenty":-19.040057,"median":-18.074879,"eighty":-17.195892,"marketCap":19375591509},{"date":"2021-07-16","current":-15.969405,"twenty":-19.032975,"median":-18.040488,"eighty":-17.122755,"marketCap":19022319855},{"date":"2021-07-23","current":-15.856864,"twenty":-19.023636,"median":-18.026565,"eighty":-17.079749,"marketCap":18886446141},{"date":"2021-07-30","current":-14.666803,"twenty":-18.986811,"median":-17.998882,"eighty":-16.849549,"marketCap":17527709009},{"date":"2021-08-06","current":-14.588335,"twenty":-18.965589,"median":-17.945733,"eighty":-16.750714,"marketCap":17391835296},{"date":"2021-08-13","current":-14.52296,"twenty":-18.953047,"median":-17.911145,"eighty":-16.470265,"marketCap":17337485810},{"date":"2021-08-20","current":-13.520478,"twenty":-18.945494,"median":-17.88088,"eighty":-16.251298,"marketCap":15217855884},{"date":"2021-08-27","current":-12.980395,"twenty":-18.88847,"median":-17.842996,"eighty":-16.122732,"marketCap":14674361031},{"date":"2021-09-03","current":-12.734842,"twenty":-18.882406,"median":-17.809029,"eighty":-15.859736,"marketCap":14402613604},{"date":"2021-09-10","current":-13.373232,"twenty":-18.846812,"median":-17.803134,"eighty":-15.761703,"marketCap":15163506398},{"date":"2021-09-17","current":-12.138916,"twenty":-18.846135,"median":-17.730953,"eighty":-15.089723,"marketCap":13723245038},{"date":"2021-09-24","current":-11.82096,"twenty":-18.810911,"median":-17.571343,"eighty":-14.867281,"marketCap":13369973383},{"date":"2021-09-30","current":-11.757587,"twenty":-18.785539,"median":-17.567074,"eighty":-14.603567,"marketCap":13342798641},{"date":"2021-10-08","current":-10.872073,"twenty":-18.769634,"median":-17.476946,"eighty":-14.333569,"marketCap":12337333163},{"date":"2021-10-15","current":-12.085096,"twenty":-18.725638,"median":-17.441951,"eighty":-13.86094,"marketCap":13723245038},{"date":"2021-10-22","current":-11.832626,"twenty":-18.639753,"median":-17.36388,"eighty":-13.648942,"marketCap":13533021839},{"date":"2021-10-29","current":-12.004873,"twenty":-18.601961,"median":-17.24697,"eighty":-13.384811,"marketCap":13696070295},{"date":"2021-11-05","current":-11.842443,"twenty":-18.587887,"median":-17.177529,"eighty":-13.069878,"marketCap":13533021839},{"date":"2021-11-12","current":-13.238443,"twenty":-18.539285,"median":-17.121354,"eighty":-12.950721,"marketCap":15190681141},{"date":"2021-11-19","current":-13.755236,"twenty":-18.493787,"median":-17.09849,"eighty":-12.989283,"marketCap":15761350737},{"date":"2021-11-26","current":-15.860878,"twenty":-18.471737,"median":-16.981974,"eighty":-13.021471,"marketCap":18179902832},{"date":"2021-12-03","current":-12.565895,"twenty":-18.441097,"median":-16.849549,"eighty":-12.989283,"marketCap":14429788347},{"date":"2021-12-10","current":-13.678439,"twenty":-18.435344,"median":-16.791123,"eighty":-12.950721,"marketCap":15734175994},{"date":"2021-12-17","current":-13.900665,"twenty":-18.427924,"median":-16.72442,"eighty":-12.950721,"marketCap":15978748678},{"date":"2021-12-24","current":-12.068814,"twenty":-18.41961,"median":-16.57278,"eighty":-12.854432,"marketCap":13886293494},{"date":"2021-12-31","current":-10.392945,"twenty":-18.411685,"median":-16.313069,"eighty":-12.599684,"marketCap":11984061508},{"date":"2022-01-07","current":-10.408899,"twenty":-11.114507,"median":-10.603378,"eighty":-10.458171,"marketCap":11956886766},{"date":"2022-01-14","current":-10.645935,"twenty":-11.136014,"median":-10.825867,"eighty":-10.516719,"marketCap":12255808935},{"date":"2022-01-21","current":-11.846284,"twenty":-11.23402,"median":-10.950741,"eighty":-10.575568,"marketCap":13668895552},{"date":"2022-01-28","current":-10.719633,"twenty":-11.23402,"median":-10.92037,"eighty":-10.575568,"marketCap":12337333163},{"date":"2022-02-04","current":-10.961121,"twenty":-11.226983,"median":-10.955931,"eighty":-10.603378,"marketCap":12609080589},{"date":"2022-02-11","current":-11.151206,"twenty":-11.195149,"median":-10.961121,"eighty":-10.645935,"marketCap":12853653273},{"date":"2022-02-18","current":-10.838643,"twenty":-11.151206,"median":-10.933229,"eighty":-10.645935,"marketCap":12554731104},{"date":"2022-02-25","current":-10.531157,"twenty":-11.149804,"median":-10.879658,"eighty":-10.555938,"marketCap":12228634192},{"date":"2022-03-04","current":-10.223007,"twenty":-11.133246,"median":-10.844907,"eighty":-10.526339,"marketCap":11875362538},{"date":"2022-03-11","current":-8.809298,"twenty":-11.096591,"median":-10.772075,"eighty":-10.439214,"marketCap":10217703236},{"date":"2022-03-18","current":-8.973146,"twenty":-11.067899,"median":-10.693082,"eighty":-10.247041,"marketCap":10859027162},{"date":"2022-03-25","current":-9.408384,"twenty":-11.060746,"median":-10.645935,"eighty":-9.613254,"marketCap":11386217170},{"date":"2022-04-01","current":-8.944167,"twenty":-11.060302,"median":-10.579658,"eighty":-9.555081,"marketCap":10837287368},{"date":"2022-04-08","current":-9.101703,"twenty":-11.051173,"median":-10.532504,"eighty":-9.487781,"marketCap":11032945515},{"date":"2022-04-14","current":-8.829357,"twenty":-10.996229,"median":-10.520302,"eighty":-9.272441,"marketCap":10685108809},{"date":"2022-04-22","current":-8.439191,"twenty":-10.958109,"median":-10.475675,"eighty":-9.02764,"marketCap":10022045089},{"date":"2022-04-29","current":-9.033079,"twenty":-10.95245,"median":-10.408899,"eighty":-8.917879,"marketCap":10554670045},{"date":"2022-05-06","current":-7.41082,"twenty":-10.943736,"median":-10.392945,"eighty":-8.839536,"marketCap":8587218677},{"date":"2022-05-13","current":-7.364351,"twenty":-10.915716,"median":-10.223007,"eighty":-8.8007,"marketCap":8380690633},{"date":"2022-05-20","current":-7.968917,"twenty":-10.889999,"median":-9.98237,"eighty":-8.584099,"marketCap":9195932912},{"date":"2022-05-27","current":-7.542162,"twenty":-10.879658,"median":-9.877618,"eighty":-8.1017,"marketCap":8695917648},{"date":"2022-06-02","current":-7.839485,"twenty":-10.877545,"median":-9.647965,"eighty":-8.02985,"marketCap":9087233942},{"date":"2022-06-10","current":-8.770543,"twenty":-10.856339,"median":-9.531356,"eighty":-7.992051,"marketCap":10098134368},{"date":"2022-06-17","current":-8.742365,"twenty":-10.841148,"median":-9.348726,"eighty":-8.004315,"marketCap":10054654780},{"date":"2022-06-24","current":-8.23701,"twenty":-10.797885,"median":-9.166898,"eighty":-8.03147,"marketCap":9511159927},{"date":"2022-06-30","current":-8.326656,"twenty":-10.778323,"median":-9.060482,"eighty":-8.076162,"marketCap":9598119103},{"date":"2022-07-08","current":-8.497078,"twenty":-10.769546,"median":-8.973146,"eighty":-8.128672,"marketCap":9804647148},{"date":"2022-07-15","current":-8.681154,"twenty":-10.738924,"median":-8.890871,"eighty":-8.173221,"marketCap":9924216015},{"date":"2022-07-22","current":-8.295377,"twenty":-10.687772,"median":-8.843947,"eighty":-8.192495,"marketCap":9489420133},{"date":"2022-07-29","current":-7.886667,"twenty":-10.657029,"median":-8.819327,"eighty":-8.057303,"marketCap":9032884456},{"date":"2022-08-05","current":-7.136107,"twenty":-10.647839,"median":-8.783241,"eighty":-7.981108,"marketCap":8152422795},{"date":"2022-08-12","current":-7.088387,"twenty":-10.632543,"median":-8.711759,"eighty":-7.937979,"marketCap":8108943206},{"date":"2022-08-19","current":-8.891947,"twenty":-10.611473,"median":-8.651267,"eighty":-7.857437,"marketCap":8619828368},{"date":"2022-08-26","current":-9.878492,"twenty":-10.574914,"median":-8.756454,"eighty":-7.879762,"marketCap":9500290030},{"date":"2022-09-02","current":-9.641847,"twenty":-10.542686,"median":-8.8007,"eighty":-7.911799,"marketCap":9239412501},{"date":"2022-09-09","current":-8.585571,"twenty":-10.532235,"median":-8.776892,"eighty":-7.937979,"marketCap":8195902383},{"date":"2022-09-16","current":-8.205928,"twenty":-10.52923,"median":-8.711759,"eighty":-7.947262,"marketCap":7761106500},{"date":"2022-09-23","current":-7.850954,"twenty":-10.521509,"median":-8.645731,"eighty":-7.931397,"marketCap":7282831030},{"date":"2022-09-30","current":-6.666434,"twenty":-10.504967,"median":-8.625033,"eighty":-7.852429,"marketCap":6195841324},{"date":"2022-10-07","current":-6.701906,"twenty":-10.484881,"median":-8.591202,"eighty":-7.761108,"marketCap":6228451015},{"date":"2022-10-14","current":-7.35301,"twenty":-10.456108,"median":-8.583249,"eighty":-7.57143,"marketCap":6761075971},{"date":"2022-10-21","current":-7.951253,"twenty":-10.433151,"median":-8.545175,"eighty":-7.57143,"marketCap":7261091236},{"date":"2022-10-28","current":-6.796392,"twenty":-10.406061,"median":-8.508514,"eighty":-7.508003,"marketCap":6195841324},{"date":"2022-11-04","current":-6.754512,"twenty":-10.394357,"median":-8.473127,"eighty":-7.42644,"marketCap":6217581118},{"date":"2022-11-11","current":-6.097932,"twenty":-10.363764,"median":-8.469242,"eighty":-7.395321,"marketCap":5663216368},{"date":"2022-11-18","current":-6.753098,"twenty":-10.242234,"median":-8.45243,"eighty":-7.346759,"marketCap":6250190809},{"date":"2022-11-25","current":-6.736071,"twenty":-10.196623,"median":-8.439191,"eighty":-7.272097,"marketCap":6184971427},{"date":"2022-12-02","current":-7.773909,"twenty":-10.077914,"median":-8.37957,"eighty":-7.241589,"marketCap":7261091236},{"date":"2022-12-09","current":-8.002157,"twenty":-10.008085,"median":-8.295377,"eighty":-7.250791,"marketCap":7543708559},{"date":"2022-12-16","current":-7.535454,"twenty":-9.932205,"median":-8.278653,"eighty":-7.272097,"marketCap":7087172883},{"date":"2022-12-23","current":-7.51,"twenty":-9.898083,"median":-8.243002,"eighty":-7.316458,"marketCap":7065433089},{"date":"2022-12-30","current":-7.305703,"twenty":-9.88339,"median":-8.22445,"eighty":-7.296997,"marketCap":6956734118},{"date":"2023-01-06","current":-7.457393,"twenty":-9.877968,"median":-8.206319,"eighty":-7.311066,"marketCap":7174132059},{"date":"2023-01-13","current":-8.437239,"twenty":-9.858414,"median":-8.206709,"eighty":-7.320093,"marketCap":8271991662},{"date":"2023-01-20","current":-8.286606,"twenty":-9.834445,"median":-8.240006,"eighty":-7.327535,"marketCap":8054593721},{"date":"2023-01-27","current":-8.57561,"twenty":-9.827001,"median":-8.248307,"eighty":-7.330074,"marketCap":8337211045},{"date":"2023-02-03","current":-8.175491,"twenty":-9.75546,"median":-8.23701,"eighty":-7.341519,"marketCap":7989374339},{"date":"2023-02-10","current":-7.777299,"twenty":-9.742113,"median":-8.206319,"eighty":-7.345196,"marketCap":7554578456},{"date":"2023-02-17","current":-8.009725,"twenty":-9.697444,"median":-8.193537,"eighty":-7.35301,"marketCap":7706757015},{"date":"2023-02-24","current":-8.177484,"twenty":-9.647965,"median":-8.202583,"eighty":-7.359122,"marketCap":7771976397},{"date":"2023-03-03","current":-8.136456,"twenty":-9.641847,"median":-8.205928,"eighty":-7.362303,"marketCap":7782846294},{"date":"2023-03-10","current":-7.532958,"twenty":-7.936227,"median":-7.807589,"eighty":-7.663468,"marketCap":7152392265},{"date":"2023-03-17","current":-6.893844,"twenty":-29.280721,"median":-16.418697,"eighty":-8.337386,"marketCap":6608897412},{"date":"2023-03-24","current":-6.658655,"twenty":-29.278482,"median":-16.330752,"eighty":-8.295377,"marketCap":6456718853},{"date":"2023-03-31","current":-6.382321,"twenty":-29.265473,"median":-16.265645,"eighty":-8.279201,"marketCap":6141491838},{"date":"2023-04-06","current":-6.996826,"twenty":-29.261938,"median":-16.251298,"eighty":-8.277923,"marketCap":6728466280},{"date":"2023-04-14","current":-9.166043,"twenty":-29.244948,"median":-16.177122,"eighty":-8.278324,"marketCap":7282831030},{"date":"2023-04-21","current":-10.375279,"twenty":-29.156297,"median":-16.110434,"eighty":-8.280198,"marketCap":8239381971},{"date":"2023-04-28","current":-9.791172,"twenty":-28.966769,"median":-16.017528,"eighty":-8.284669,"marketCap":7717626912},{"date":"2023-05-05","current":-9.403412,"twenty":-28.879119,"median":-15.969405,"eighty":-8.286606,"marketCap":7424139691},{"date":"2023-05-12","current":-9.274529,"twenty":-28.852641,"median":-15.860307,"eighty":-8.292601,"marketCap":7271961133},{"date":"2023-05-19","current":-8.816242,"twenty":-28.781694,"median":-15.853497,"eighty":-8.295377,"marketCap":6815425456},{"date":"2023-05-25","current":-7.906691,"twenty":-28.683645,"median":-15.812226,"eighty":-8.286122,"marketCap":6087142353},{"date":"2023-06-02","current":-7.650251,"twenty":-28.635789,"median":-15.707766,"eighty":-8.27382,"marketCap":5869744412},{"date":"2023-06-09","current":-7.718055,"twenty":-28.62839,"median":-15.523719,"eighty":-8.241804,"marketCap":5913224000},{"date":"2023-06-16","current":-8.211383,"twenty":-28.539889,"median":-15.189066,"eighty":-8.211383,"marketCap":6261060706},{"date":"2023-06-23","current":-7.66872,"twenty":-28.479972,"median":-15.018009,"eighty":-8.206397,"marketCap":5815394927},{"date":"2023-06-30","current":-8.028021,"twenty":-28.434831,"median":-14.894025,"eighty":-8.185553,"marketCap":6032792868},{"date":"2023-07-07","current":-9.203166,"twenty":-28.42021,"median":-14.728988,"eighty":-8.185553,"marketCap":6902384633},{"date":"2023-07-14","current":-9.275907,"twenty":-28.374356,"median":-14.588335,"eighty":-8.192495,"marketCap":7054563191},{"date":"2023-07-21","current":-9.07511,"twenty":-28.325294,"median":-14.52296,"eighty":-8.195817,"marketCap":6869774941},{"date":"2023-07-28","current":-9.214207,"twenty":-28.276566,"median":-14.467488,"eighty":-8.201914,"marketCap":6967604015},{"date":"2023-08-04","current":-8.538775,"twenty":-28.107178,"median":-14.183362,"eighty":-8.20624,"marketCap":6467588750},{"date":"2023-08-11","current":-8.096561,"twenty":-27.877746,"median":-13.991007,"eighty":-8.191975,"marketCap":6098012250},{"date":"2023-08-18","current":-7.762464,"twenty":-27.830986,"median":-13.842305,"eighty":-8.175132,"marketCap":5804525030},{"date":"2023-08-25","current":-26.697795,"twenty":-27.784384,"median":-13.828395,"eighty":-8.158004,"marketCap":5837134721},{"date":"2023-09-01","current":-29.706597,"twenty":-28.107178,"median":-13.888892,"eighty":-8.170209,"marketCap":6521938236},{"date":"2023-09-08","current":-30.060486,"twenty":-28.420665,"median":-14.123754,"eighty":-8.173421,"marketCap":6521938236},{"date":"2023-09-15","current":-29.580626,"twenty":-28.629171,"median":-14.286381,"eighty":-8.175132,"marketCap":6467588750},{"date":"2023-09-22","current":-28.661921,"twenty":-28.647461,"median":-14.50559,"eighty":-8.176288,"marketCap":6239320912},{"date":"2023-09-29","current":-25.921048,"twenty":-28.629171,"median":-14.562003,"eighty":-8.182864,"marketCap":5652346471},{"date":"2023-10-06","current":-24.561986,"twenty":-28.613095,"median":-14.613721,"eighty":-8.191454,"marketCap":5353424302},{"date":"2023-10-13","current":-26.92125,"twenty":-28.546356,"median":-14.838741,"eighty":-8.194677,"marketCap":5858874515},{"date":"2023-10-20","current":-24.986856,"twenty":-28.505231,"median":-14.94306,"eighty":-8.200576,"marketCap":5429513581},{"date":"2023-10-27","current":-30.077169,"twenty":-28.55348,"median":-15.089723,"eighty":-8.205928,"marketCap":6532808133},{"date":"2023-11-03","current":-36.685816,"twenty":-28.661921,"median":-15.342423,"eighty":-8.206709,"marketCap":7989374339},{"date":"2023-11-10","current":-34.996098,"twenty":-28.781694,"median":-15.589929,"eighty":-8.211383,"marketCap":7619797839},{"date":"2023-11-17","current":139.007258,"twenty":-28.852641,"median":-15.556824,"eighty":-8.205928,"marketCap":8271991662},{"date":"2023-11-24","current":134.06759,"twenty":-28.781694,"median":-15.273067,"eighty":-8.177484,"marketCap":8043723824},{"date":"2023-12-01","current":123.410206,"twenty":-28.717643,"median":-15.018009,"eighty":-8.168722,"marketCap":7435009589},{"date":"2023-12-08","current":115.396674,"twenty":-28.676471,"median":-14.894025,"eighty":-8.136456,"marketCap":6924124427},{"date":"2023-12-15","current":112.572734,"twenty":-28.665909,"median":-14.728988,"eighty":-8.09843,"marketCap":6793685662},{"date":"2023-12-22","current":105.438504,"twenty":-28.661921,"median":-14.588335,"eighty":-8.0768,"marketCap":6358889780},{"date":"2023-12-29","current":124.600197,"twenty":-28.660248,"median":-14.542482,"eighty":-8.068487,"marketCap":7554578456},{"date":"2024-01-05","current":123.318541,"twenty":-28.647461,"median":-14.50559,"eighty":-8.040462,"marketCap":7424139691},{"date":"2024-01-12","current":129.388505,"twenty":-28.629171,"median":-14.286381,"eighty":-8.023906,"marketCap":7793716192},{"date":"2024-01-19","current":128.482233,"twenty":-28.598191,"median":-14.123754,"eighty":-8.004007,"marketCap":7728496809},{"date":"2024-01-26","current":127.895751,"twenty":-28.539232,"median":-13.888892,"eighty":-7.991336,"marketCap":7663277427},{"date":"2024-02-02","current":117.16038,"twenty":-28.492602,"median":-13.828395,"eighty":-7.968917,"marketCap":7011083603},{"date":"2024-02-09","current":116.043963,"twenty":-28.441459,"median":-13.741036,"eighty":-7.955731,"marketCap":6978473912},{"date":"2024-02-16","current":117.464597,"twenty":-28.421577,"median":-13.690402,"eighty":-7.951253,"marketCap":7065433089},{"date":"2024-02-23","current":117.542093,"twenty":-28.419298,"median":-13.613328,"eighty":-7.941856,"marketCap":7032823397},{"date":"2024-03-01","current":119.647539,"twenty":-28.344394,"median":-13.512101,"eighty":-7.915092,"marketCap":7163262162},{"date":"2024-03-08","current":126.672019,"twenty":-28.296644,"median":-13.425131,"eighty":-7.869405,"marketCap":7587188147},{"date":"2024-03-15","current":136.411129,"twenty":-28.24645,"median":-13.3476,"eighty":-7.842873,"marketCap":8163292692},{"date":"2024-03-22","current":12.973937,"twenty":-28.044189,"median":-13.218965,"eighty":-7.777299,"marketCap":7695887118},{"date":"2024-03-28","current":12.519209,"twenty":-28.009087,"median":-13.100065,"eighty":-7.772172,"marketCap":7402399897},{"date":"2024-04-05","current":13.37366,"twenty":-27.959496,"median":-13.038286,"eighty":-7.76525,"marketCap":7902415162},{"date":"2024-04-12","current":13.568308,"twenty":-27.877746,"median":-12.982107,"eighty":-7.733431,"marketCap":8021984030},{"date":"2024-04-19","current":13.635105,"twenty":-27.845088,"median":-12.954555,"eighty":-7.711179,"marketCap":8054593721},{"date":"2024-04-26","current":15.199524,"twenty":-27.834055,"median":-12.900046,"eighty":-7.66971,"marketCap":8967665074},{"date":"2024-05-03","current":15.30222,"twenty":-27.818775,"median":-12.756941,"eighty":-7.639641,"marketCap":9022014559},{"date":"2024-05-10","current":15.81776,"twenty":-27.795706,"median":-12.554537,"eighty":-7.60133,"marketCap":9348111471},{"date":"2024-05-17","current":16.559383,"twenty":-27.750416,"median":-12.52579,"eighty":-7.583293,"marketCap":9772037456},{"date":"2024-05-24","current":17.391151,"twenty":-27.748227,"median":-12.491199,"eighty":-7.548422,"marketCap":10239443030},{"date":"2024-05-31","current":17.373469,"twenty":-27.745702,"median":-12.342599,"eighty":-7.532958,"marketCap":10239443030},{"date":"2024-06-07","current":17.395042,"twenty":-27.698671,"median":-12.324879,"eighty":-7.475268,"marketCap":10239443030},{"date":"2024-06-14","current":17.410995,"twenty":-27.635676,"median":-12.220722,"eighty":-7.447557,"marketCap":10239443030},{"date":"2024-06-21","current":17.44752,"twenty":-27.579411,"median":-12.146878,"eighty":-7.429881,"marketCap":10239443030},{"date":"2024-06-28","current":21.169921,"twenty":-27.531991,"median":-12.107468,"eighty":-7.409463,"marketCap":12418857391},{"date":"2024-07-05","current":21.31352,"twenty":-27.509142,"median":-12.073098,"eighty":-7.391342,"marketCap":12500381619},{"date":"2024-07-12","current":20.958398,"twenty":-27.436,"median":-12.028963,"eighty":-7.356677,"marketCap":12310158420},{"date":"2024-07-19","current":20.772946,"twenty":-27.320477,"median":-12.010321,"eighty":-7.327535,"marketCap":12201459449},{"date":"2024-07-26","current":20.696058,"twenty":-27.195166,"median":-11.942483,"eighty":-7.298439,"marketCap":12201459449},{"date":"2024-08-02","current":20.846486,"twenty":-27.093894,"median":-11.893713,"eighty":-7.252794,"marketCap":12282983677},{"date":"2024-08-09","current":20.754283,"twenty":-27.015113,"median":-11.837535,"eighty":-7.211803,"marketCap":12310158420},{"date":"2024-08-16","current":21.066803,"twenty":-26.967771,"median":-11.806904,"eighty":-7.168418,"marketCap":12500381619},{"date":"2024-08-23","current":20.886927,"twenty":-26.955307,"median":-11.609004,"eighty":-7.109109,"marketCap":12446032133},{"date":"2024-08-30","current":16.43423,"twenty":-26.948522,"median":-11.548619,"eighty":-6.995646,"marketCap":12500381619},{"date":"2024-09-06","current":16.533448,"twenty":-26.930541,"median":-11.45821,"eighty":-6.871599,"marketCap":12581905846},{"date":"2024-09-13","current":16.576841,"twenty":-26.803138,"median":-11.259414,"eighty":-6.79064,"marketCap":12581905846},{"date":"2024-09-20","current":16.406845,"twenty":-26.713756,"median":-11.226983,"eighty":-6.778362,"marketCap":12527556361},{"date":"2024-09-27","current":16.0965,"twenty":-26.474991,"median":-11.12377,"eighty":-6.734055,"marketCap":12364507905},{"date":"2024-10-04","current":16.063334,"twenty":-26.12212,"median":-11.064322,"eighty":-6.695364,"marketCap":12282983677},{"date":"2024-10-10","current":16.275333,"twenty":-25.921214,"median":-11.005246,"eighty":-6.664268,"marketCap":12364507905},{"date":"2024-10-18","current":16.144897,"twenty":-25.637712,"median":-10.902857,"eighty":-6.619301,"marketCap":12201459449},{"date":"2024-10-25","current":15.534605,"twenty":-25.112408,"median":-10.861622,"eighty":-6.595078,"marketCap":11739488824},{"date":"2024-11-01","current":15.739753,"twenty":-24.881781,"median":-10.769967,"eighty":-6.445564,"marketCap":11902537280},{"date":"2024-11-08","current":15.16169,"twenty":-24.562552,"median":-10.648314,"eighty":-6.336141,"marketCap":11413391913},{"date":"2024-11-15","current":14.703704,"twenty":-23.751057,"median":-10.532504,"eighty":12.609275,"marketCap":10951421287},{"date":"2024-11-22","current":14.783679,"twenty":-23.53783,"median":-10.449772,"eighty":13.062987,"marketCap":11005770773},{"date":"2024-11-29","current":15.706785,"twenty":-22.999838,"median":-10.31116,"eighty":13.490644,"marketCap":11685139339},{"date":"2024-12-06","current":16.219845,"twenty":-22.435947,"median":-10.035329,"eighty":13.731242,"marketCap":12038410993},{"date":"2024-12-13","current":16.288608,"twenty":-22.216491,"median":-9.890736,"eighty":14.555832,"marketCap":12065585736},{"date":"2024-12-20","current":17.613984,"twenty":-22.004449,"median":-9.806112,"eighty":14.82169,"marketCap":12989526986},{"date":"2024-12-27","current":17.627659,"twenty":-21.549335,"median":-9.748786,"eighty":14.920514,"marketCap":12989526986},{"date":"2025-01-03","current":17.426208,"twenty":-21.059501,"median":-9.644906,"eighty":15.101644,"marketCap":12853653273},{"date":"2025-01-10","current":17.15965,"twenty":-20.607327,"median":-9.566598,"eighty":15.217942,"marketCap":12609080589},{"date":"2025-01-17","current":14.05661,"twenty":-20.35213,"median":-9.486199,"eighty":15.260472,"marketCap":10337272104},{"date":"2025-01-24","current":11.824511,"twenty":-20.071108,"median":-9.37996,"eighty":15.260472,"marketCap":8750267133},{"date":"2025-01-28","current":12.245071,"twenty":-20.059273,"median":-9.37213,"eighty":15.246556,"marketCap":9108973736},{"date":"2025-02-07","current":14.732138,"twenty":-19.881739,"median":-9.29934,"eighty":15.274388,"marketCap":10897071802},{"date":"2025-02-14","current":15.503935,"twenty":-19.716064,"median":-9.259788,"eighty":15.394257,"marketCap":11440566655},{"date":"2025-02-21","current":15.602496,"twenty":-19.58997,"median":-9.203166,"eighty":15.430255,"marketCap":11576440368},{"date":"2025-02-28","current":20.173929,"twenty":-19.487135,"median":-9.138682,"eighty":15.600316,"marketCap":14918933714},{"date":"2025-03-07","current":22.691836,"twenty":-19.370014,"median":-9.081498,"eighty":15.678831,"marketCap":16848340443},{"date":"2025-03-14","current":22.646997,"twenty":-19.065782,"median":-8.992114,"eighty":15.77216,"marketCap":16821165700},{"date":"2025-03-21","current":22.326485,"twenty":-18.982567,"median":-8.937842,"eighty":15.869892,"marketCap":16576593016},{"date":"2025-03-28","current":21.446687,"twenty":-18.934089,"median":-8.881066,"eighty":15.958854,"marketCap":18832096656},{"date":"2025-04-03","current":20.496847,"twenty":-18.839523,"median":-8.833895,"eighty":16.064644,"marketCap":17962504891},{"date":"2025-04-11","current":17.855677,"twenty":-18.683014,"median":-8.776892,"eighty":16.101901,"marketCap":15543952795},{"date":"2025-04-17","current":21.145085,"twenty":-18.601961,"median":-8.681154,"eighty":16.211906,"marketCap":18451650259},{"date":"2025-04-25","current":23.553782,"twenty":-18.443201,"median":-8.6186,"eighty":16.246671,"marketCap":20571280186},{"date":"2025-05-02","current":25.056257,"twenty":-18.421123,"median":-8.595918,"eighty":16.285953,"marketCap":21930017318},{"date":"2025-05-09","current":21.736701,"twenty":-18.357986,"median":-8.578328,"eighty":16.307243,"marketCap":19158193568},{"date":"2025-05-16","current":24.221218,"twenty":-18.226089,"median":-8.538775,"eighty":16.352589,"marketCap":21522396178},{"date":"2025-05-23","current":25.67354,"twenty":-18.094256,"median":-8.474772,"eighty":16.43423,"marketCap":22881133311},{"date":"2025-05-30","current":28.32371,"twenty":-18.042007,"median":-8.459142,"eighty":16.529212,"marketCap":25354034892},{"date":"2025-06-06","current":27.615744,"twenty":-18.001357,"median":-8.448171,"eighty":16.543914,"marketCap":24783365296},{"date":"2025-06-13","current":28.93664,"twenty":-17.933569,"median":-8.429191,"eighty":16.59113,"marketCap":25979053973},{"date":"2025-06-20","current":29.114781,"twenty":-17.88088,"median":-8.326656,"eighty":16.663735,"marketCap":26087752944},{"date":"2025-06-27","current":30.394421,"twenty":-17.812992,"median":-8.289604,"eighty":17.360329,"marketCap":27310616363},{"date":"2025-07-04","current":33.810314,"twenty":-17.801509,"median":-8.277953,"eighty":17.373683,"marketCap":30381362282},{"date":"2025-07-11","current":31.664802,"twenty":-17.567437,"median":-8.248047,"eighty":17.392581,"marketCap":28424780811},{"date":"2025-07-18","current":38.172983,"twenty":-17.446462,"median":-8.211383,"eighty":17.398695,"marketCap":34240175739},{"date":"2025-07-25","current":37.581872,"twenty":-17.327692,"median":-8.192235,"eighty":17.415819,"marketCap":33832554599},{"date":"2025-08-01","current":40.093578,"twenty":-17.167788,"median":-8.170581,"eighty":17.4341,"marketCap":35870660298},{"date":"2025-08-08","current":44.992727,"twenty":-17.097162,"median":-8.121718,"eighty":17.480128,"marketCap":40354492835},{"date":"2025-08-15","current":50.734499,"twenty":-17.058582,"median":-8.093911,"eighty":17.621631,"marketCap":45436169710},{"date":"2025-08-22","current":50.833217,"twenty":-16.859598,"median":-8.068042,"eighty":18.705535,"marketCap":45381820225},{"date":"2025-08-29","current":46.979642,"twenty":-16.745455,"median":-8.037018,"eighty":20.138159,"marketCap":42338249048},{"date":"2025-09-05","current":49.410758,"twenty":-16.617085,"median":-8.00783,"eighty":20.53569,"marketCap":44485053718},{"date":"2025-09-12","current":47.905886,"twenty":-16.339663,"median":-7.991861,"eighty":20.742638,"marketCap":43207840813},{"date":"2025-09-19","current":46.794173,"twenty":-16.219396,"median":-7.96845,"eighty":20.789539,"marketCap":42175200592},{"date":"2025-09-26","current":43.258153,"twenty":-16.026591,"median":-7.951507,"eighty":20.858338,"marketCap":38887056732},{"date":"2025-10-03","current":44.331295,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"marketCap":39946871695},{"date":"2025-10-10","current":43.248336,"twenty":-15.847839,"median":-7.921823,"eighty":20.912054,"marketCap":38914231474},{"date":"2025-10-17","current":43.312255,"twenty":-15.64105,"median":-7.867054,"eighty":20.962367,"marketCap":38941406217},{"date":"2025-10-24","current":42.027527,"twenty":-15.101997,"median":-7.840525,"eighty":21.030606,"marketCap":37800067026},{"date":"2025-10-31","current":42.145948,"twenty":-14.892482,"median":-7.774922,"eighty":21.062977,"marketCap":37963115482},{"date":"2025-11-07","current":36.889434,"twenty":-14.583069,"median":-7.760491,"eighty":21.163007,"marketCap":33207535518},{"date":"2025-11-14","current":40.397492,"twenty":-14.413417,"median":-7.721802,"eighty":21.238988,"marketCap":36468504636},{"date":"2025-11-21","current":38.428633,"twenty":-13.89831,"median":-7.676709,"eighty":21.585681,"marketCap":34674971621},{"date":"2025-11-28","current":41.440339,"twenty":-13.752396,"median":-7.636297,"eighty":22.072269,"marketCap":37528319599},{"date":"2025-12-05","current":40.470534,"twenty":-13.594758,"median":-7.584132,"eighty":22.535186,"marketCap":36713077320},{"date":"2025-12-11","current":38.691477,"twenty":-13.477246,"median":-7.559702,"eighty":22.956206,"marketCap":35164116989}],"updateTime":1765571336637},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02696\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1124470091","title":"Hong Kong Stock Market Analysis | Various Manipulations Behind Many Strategies and Severe Volume Reduction Favours Consumer Giants","url":"https://stock-news.laohu8.com/highlight/detail?id=1124470091","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124470091?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:40","pubTimestamp":1760618438,"startTime":"0","endTime":"0","summary":"【Market Overview】Today, both stock markets are experiencing significant volume reductions, indicating a considerable amount of cautious capital on the sidelines, making it difficult to see any...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226288170.HKD","LU1634259391.SGD","LU0348767384.USD","LU0164865239.USD","LU1152091754.HKD","00788","BK1514","LU2778985437.USD","LU0173614495.USD","BK1166","LU0561508036.HKD","LU1226287529.USD","SG9999012710.SGD","LU1226287875.USD","LU1720050803.USD","01138","LU0164880469.USD","SG9999006597.SGD","00670","BK1500","BK1183","BK1198","LU2097828474.EUR","BK1529","LU1655091616.SGD","LU2328871848.SGD","IE00B543WZ88.USD","SG9999012744.USD","80883","02628","BK1589","00316","BK1610","LU0287142896.SGD","LU2488822045.USD","LU0149721374.USD","LU1634259557.SGD","LU0051755006.USD","LU1497733557.USD","LU1951186391.HKD","LU1064130708.USD","SG9999012728.SGD","IE00BG0RBZ43.SGD","LU0327786744.USD","LU2097828805.USD","LU0228659784.USD","LU2097828557.USD","02601","BK1574","LU2476274720.SGD","LU0456827905.SGD","BK1133","SG9999012736.USD","LU1497733631.SGD","BK1149","BK1505","BK1526","BK1152","00728","LU1008478684.HKD","LU1522347837.USD","BK1521","IE00B5MMRT66.SGD","00763","BK1123","06181","BK1584","LU0456846285.SGD","02696","BK1583","09995","LU0880133367.SGD","LU0348766576.USD","LU2097828714.EUR","LU2097828631.EUR","HK0000500386.USD","IE00BPRC5H50.USD","BK1225","02259","BK1538","HK0000252152.HKD","LU0531971595.HKD","SG9999001440.SGD","BK1535","LU1481107354.HKD","IE00BHRH8C09.USD","02097","LU0572944931.SGD","LU0348827113.USD","01919","BK1161","LU0039217434.USD","LU0348735423.USD","BK1607","LU1046422090.SGD","LU1794554557.SGD","BK1536","LU1497734951.SGD","LU0823413660.USD","LU0348825331.USD","LU1969619763.USD","LU0634319403.HKD","00762","LU1064131003.USD","LU0348783233.USD","LU0417516902.SGD","00941","LU0417516571.SGD","02050","BK1561","LU1226288253.USD","SG9999014674.SGD","LU0823413587.USD","LU1226287792.SGD","BK1136","LU2399975544.HKD","LU0307460666.USD","LU0417516738.SGD","BK1616","LU2476274308.USD","BK1227","HK0000252160.HKD","SG9999001051.SGD","BK1544","LU0540923850.HKD","BK1550","BK1233","LU0348784397.USD","IE00BHRH8D16.HKD","BK1506","LU1152091168.USD","LU1961090484.USD","BK1184","SG9999001226.SGD","LU0588546209.SGD","SG9999002463.SGD","LU0067412154.USD","00639","LU0871576103.HKD","SGXZ90724238.SGD","06869","BK1587","LU2148510915.USD","BK1523","09926","BK1103","IE0032431581.USD"],"gpt_icon":1},{"id":"1100196411","title":"HK Movers | Biomedical Stocks Surge With TransThera Sciences up 42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100196411","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100196411?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:54","pubTimestamp":1760583262,"startTime":"0","endTime":"0","summary":"Biomedical stocks surged in Hong Kong. TransThera Sciences rose 42%; 3SBio, Qyuns Therapeutics, and Henlius Biotech rose 9%; Duality Biotherapeutics rose 5%; WuXi Biologics rose 3%; WuXi AppTec rose 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"fc7ccc68210fffcf55d2ffc6613e5571","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","02696","02359","09606","02269","02509","02617"],"gpt_icon":0},{"id":"1149246957","title":"HENLIUS Pioneers New Era of Perioperative Immunotherapy Monotherapy for Gastric Cancer, H-Drug Takes Early Lead in Market Potential Exceeding $6 Billion USD","url":"https://stock-news.laohu8.com/highlight/detail?id=1149246957","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149246957?lang=en_us&edition=fundamental","pubTime":"2025-10-14 15:30","pubTimestamp":1760427053,"startTime":"0","endTime":"0","summary":"On October 9, HENLIUS announced that its self-developed PD-1 inhibitor H-drug (serplulimab) achieved the primary endpoint in its Phase III clinical trial for gastric cancer perioperative treatment...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696"],"gpt_icon":0},{"id":"2574157397","title":"Phase 3 Clinical Trial of Hansizhuang Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early Nda Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2574157397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574157397?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:39","pubTimestamp":1760013564,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUA2BD8VW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696"],"gpt_icon":0},{"id":"1181780516","title":"HENLIUS (02696): Phase 3 Clinical Trial of Hansizhuang® (Serplulimab Injection) Combined with Chemotherapy for Gastric Cancer Neoadjuvant/Adjuvant Treatment Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1181780516","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181780516?lang=en_us&edition=fundamental","pubTime":"2025-10-09 16:36","pubTimestamp":1759999005,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that a Phase 3 clinical trial comparing the company's proprietary Hansizhuang® (serplulimab injection) or placebo combined with chemotherapy (oxaliplatin + tegafur) for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2574313147","title":"Shanghai Henlius Biotech Inc announces phase 3 trial success for Hansizhuang in gastric cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2574313147","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574313147?lang=en_us&edition=fundamental","pubTime":"2025-10-09 16:36","pubTimestamp":1759998981,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Inc. announced that its phase 3 clinical study of HANSIZHUANG  in combination with chemotherapy for neo-/adjuvant treatment of gastric cancer has met its primary endpoint of event-free survival in a planned interim analysis. The results of this study were recently evaluated, but the company did not specify if or when further data will be presented. HANSIZHUANG is also being investigated in various other indications and international trials, including for small cell lung cancer and metastatic colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief on October 09, 2025, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL1FMXzt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","00656","BK1230"],"gpt_icon":0},{"id":"2574131523","title":"Shanghai Henlius Biotech - Phase 3 Study of Hansizhuang for Gastric Cancer Met Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2574131523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574131523?lang=en_us&edition=fundamental","pubTime":"2025-10-09 16:30","pubTimestamp":1759998653,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VP2F8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696"],"gpt_icon":0},{"id":"1168346051","title":"Hong Kong Stock Alert | HENLIUS (02696) Surges Over 10% as FOSUN PHARMA's Middle East Office Officially Opens in Jeddah, Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=1168346051","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168346051?lang=en_us&edition=fundamental","pubTime":"2025-10-08 14:02","pubTimestamp":1759903379,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) surged over 10% today, rising 9.33% to HK$77.95 with a trading volume of HK$82.34 million as of press time. On the news front, FOSUN PHARMA's Middle East office and joint venture...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK0188","BK0196","BK0096","BK4614","BK0175","BK0012","02196","07226","600196","YANG","BK0060","BK0187","BK1515","BK0028","02696","BK0183","BK1161","BK1191","BK0239","HSCEI"],"gpt_icon":1},{"id":"2571176345","title":"BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07","url":"https://stock-news.laohu8.com/highlight/detail?id=2571176345","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571176345?lang=en_us&edition=fundamental","pubTime":"2025-09-30 18:17","pubTimestamp":1759227439,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07Sept 30 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK:NMPA APPROVES PHASE 1B/2 TRIAL FOR HLX43 AND HLX07Further company coverage: 2696.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161"],"gpt_icon":0},{"id":"1191114042","title":"HENLIUS (02696): NMPA Approves Phase 1b/2 Clinical Trial Application for HLX43 Injection Combined with HLX07 in Advanced/Metastatic Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1191114042","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191114042?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:39","pubTimestamp":1759225191,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the National Medical Products Administration (NMPA) has recently approved its Phase 1b/2 clinical trial application for HLX43 injection (PD-L1-targeted antibody-drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696"],"gpt_icon":0},{"id":"2571348601","title":"Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2571348601","media":"Reuters","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571348601?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:31","pubTimestamp":1759224705,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China. **Shanghai Henlius Biotech Receives Regulatory Approval for New Cancer Clinical Trial** Shanghai Henlius Biotech Inc. announced that its application to conduct a Phase 1b/2 clinical trial of HLX43 for injection  in combination with HLX07  has been approved by China's National Medical Products Administration. The trial will focus on the treatment of advanced or metastatic solid tumours. Recent results from the phase 1 clinical trial, presented at the 2025 World Conference on Lung Cancer, showed promising efficacy and safety in patients with advanced solid tumours, particularly non-small cell lung cancer. The approval is specific to Shanghai Henlius Biotech Inc., with no indication of grant or funding involvement from other organizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL2SyM5f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","00656","BK1230","02696"],"gpt_icon":0},{"id":"2571348504","title":"Shanghai Henlius Biotech Inc - Nmpa Approves Phase 1B/2 Trial for Hlx43 and Hlx07","url":"https://stock-news.laohu8.com/highlight/detail?id=2571348504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571348504?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:30","pubTimestamp":1759224650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02696","BK1161"],"gpt_icon":0},{"id":"1191316700","title":"HENLIUS (02696): FDA Approves Phase 1 Clinical Trial Application for HLX13 as First-Line Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1191316700","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191316700?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:12","pubTimestamp":1759137132,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the U.S. Food and Drug Administration (FDA) has recently approved the Investigational New Drug (IND) application for a Phase 1 clinical trial of the company's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161","BK4006","HCC"],"gpt_icon":0},{"id":"2571383712","title":"Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2571383712","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571383712?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:04","pubTimestamp":1759136640,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL8f7TcZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1230","00656","02696"],"gpt_icon":0},{"id":"2571383208","title":"Shanghai Henlius Biotech Inc - FDA Approves Ind for Hlx13 for Unresectable Hcc","url":"https://stock-news.laohu8.com/highlight/detail?id=2571383208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571383208?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:01","pubTimestamp":1759136501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696"],"gpt_icon":0},{"id":"1197596150","title":"HENLIUS (02696) Completes First Patient Dosing in China for International Multi-Center Phase 1 Clinical Trial of Independently Developed Pembrolizumab Biosimilar HLX17 in Patients with Various Resected Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1197596150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197596150?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:48","pubTimestamp":1758880131,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the company has recently completed first patient dosing in China (excluding Hong Kong, Macau and Taiwan) for an international multi-center Phase 1 clinical trial of its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2570100914","title":"Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours","url":"https://stock-news.laohu8.com/highlight/detail?id=2570100914","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570100914?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:42","pubTimestamp":1758879776,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDLbmlj9V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU1989764664.SGD","BK1161","IQV","LU0130102774.USD","LU1989764748.USD","LU0130518102.USD","LU1201861249.SGD","LU0648001328.SGD","02696","LU1791710582.SGD","LU0882574055.USD","LU0477156953.USD","BK4585","BK4530","00656","LU0648000940.SGD","LU1791710400.SGD","BK4121","LU0130517989.USD","BK1230","LU0528227936.USD","BK4588","LU0477156797.USD","LU1201861165.SGD","LU0980610538.SGD","LU0130103400.USD","LU0198837287.USD"],"gpt_icon":0},{"id":"2570803802","title":"What Recent Partnership News Means for Shanghai Henlius Biotech’s Valuation in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2570803802","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570803802?lang=en_us&edition=fundamental","pubTime":"2025-09-24 22:54","pubTimestamp":1758725649,"startTime":"0","endTime":"0","summary":"Deciding what to do with Shanghai Henlius Biotech stock these days? You are definitely not alone. The stock has been making waves and, depending on your lens, could be at an intriguing crossroads. If you are watching its recent movements, you might have caught last week’s dip of -11.8%. At first glance, that could spook even seasoned investors. But zoom out and you will notice a much bigger picture: despite the short-term stumble, Henlius has delivered an eye-popping 212.6% gain year to date...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/what-recent-partnership-news-means-for-shanghai-henlius-biot","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/what-recent-partnership-news-means-for-shanghai-henlius-biot","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02696","DCF"],"gpt_icon":0},{"id":"2569733764","title":"Is Shanghai Henlius Biotech (SEHK:2696) Fairly Valued? A Fresh Look at Current Market Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2569733764","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569733764?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:11","pubTimestamp":1758543062,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) has been catching the attention of investors lately. There has not been a major event driving sudden headlines, but sometimes a period of relative calm can be just as telling, prompting new questions about what the market may be expecting from the company in the months ahead.\n\nThe stock’s journey over the last year has been anything but straightforward. While momentum has cooled in the past month, with a 7% dip, the share price is still up more than 2% for...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-fairly-valued-a-fresh-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-fairly-valued-a-fresh-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02696"],"gpt_icon":0},{"id":"2568268151","title":"European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively","url":"https://stock-news.laohu8.com/highlight/detail?id=2568268151","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568268151?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:59","pubTimestamp":1758283140,"startTime":"0","endTime":"0","summary":"SHANGHAI and JERSEY CITY, N.J., Sept. 19, 2025 /PRNewswire/ -- ShanghaiHenlius Biotech, Inc. , and Organon  today announced the European Commission  has granted marketing authorization for BILDYOS  injection 60 mg/mL and BILPREVDA  injection 120 mg/1.7 mL,biosimilars to PROLIA  and XGEVA, respectively, for all indications of the reference products.[1],[2]. \"The EC approvals of BILDYOS and BILPREVDA mark a pivotal moment in expanding access to essential bone care treatments for millions of Europeans, particularly women, who are disproportionately affected by osteoporosis,\" said Nico Van Hoecke, Head, International Commercial at Organon.[3],[4] \"These biosimilars may offer additional treatment options across several therapeutic areas associated with bone loss, including osteoporosis, and reflect Organon's commitment to advancing women's health through access to important medicines.[4] These approvals, following those in the United States, not only expand the global reach of these biosimi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/european-commission-ec-approves-henlius-and-organons-bildyos-denosumab-and-bilprevda-denosumab-biosimilars-to-prolia-denosumab-and-xgeva-denosumab-respectively-302561484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4585","02696","BK4559","EMA","LU2065170008.USD","OGN","BK4201","BK4007","LU2065171311.SGD","BK1161","EC","BK4588","LU2065171402.SGD","LU2065169927.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":150,"code":"91000000","status":"200"}]}}